BioSpace News Archive

- Senti Bio, a leading gene circuit company, today announced that company leadership will participate in two upcoming investor conferences. SVB Leerink 10 th Annual Global Healthcare Conference Date: February 23 rd Event: 1x1 Investor Meetings Barclays Global Healthcare Conference Date: March 9 th Event: Presentation (3:00 p.m. EST) Date: March 11 th Event: 1x1 Investor Meetings

Adagene Inc. (“Adagene” or the “Company”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, today announced the closing of its initial public offering (the “IPO”) of 8,457,100 American depositary shares (“ADSs”),

Qosina Corp., a leading global supplier of OEM single-use components, has partnered with EcoVadis, the world’s most trusted provider of business sustainability ratings.

Priveterra Acquisition Corp. (Nasdaq: PMGMU) (the “Company”) today announced that it closed its initial public offering of 27,600,000 units

RedHawk Holdings Corp. announced that its wholly-owned subsidiary, RedHawk Pharma LLC, has agreed to acquire certain cannabis assets of Med Tech Farms LLC, an Oklahoma-based start-up grower and supplier of cannabis products for a total of $1 million to be paid through a combination of cash, stock and convertible notes.

uLab Systems™, the creator of the uSmile™ Clear Aligner System, is proud to be featured this weekend at the American Association of Orthodontists (AAO) Winter Conference

BioUtah and the University of Utah ’ s PIVOT Center Announce Headline Speakers, Agenda for 2021 Virtual Entrepreneur & Investor Life Sciences Summit Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare innovation at the February 25-26 noted Utah life sciences event

Safeguard Scientifics, Inc. announced that it will host a virtual discussion with Sundeep Bhan, CEO of Prognos Health at 10:00 a.m. ET on Tuesday, February 23, 2021.

Collegium Pharmaceutical, Inc. announced that the Company will host a conference call and live audio webcast on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time.

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, today reported its financial results for the three-month period ended December 31, 2020.